Literature DB >> 17570710

Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery.

Hemin Nie1, Beng Wee Soh, Yin-Chih Fu, Chi-Hwa Wang.   

Abstract

A protein loaded three-dimensional scaffold can be used for protein delivery and bone tissue regeneration. The main objective of this project was to develop recombinant human bone morphogenetic protein-2 (rhBMP-2) loaded poly(D,L-lactide-co-glycolide)/hydroxylapatite (PLGA/HAp) composite fibrous scaffolds through a promising fabrication technique, electrospinning. In vitro release of BMP-2 from these scaffolds, and the attachment ability and viability of marrow derived messenchymal stem cells (MSCs) in the presence of the scaffolds were investigated. The PLGA/HAp composite scaffolds developed in this study exhibit good morphology and it was observed that HAp nanoparticles were homogeneously dispersed inside PLGA matrix within the scaffold. The composite scaffolds allowed sustained (2-8 weeks) release of BMP-2 whose release rate was accelerated with increasing HAp content. It was also shown that BMP-2 protein successfully maintained its integrity and natural conformations after undergoing the process of electrospinning. Cell culture experiments showed that the encapsulation of HAp could enhance cell attachment to scaffolds and lower cytotoxicity. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17570710     DOI: 10.1002/bit.21517

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  33 in total

Review 1.  Electrospun nanofibrous materials for tissue engineering and drug delivery.

Authors:  Wenguo Cui; Yue Zhou; Jiang Chang
Journal:  Sci Technol Adv Mater       Date:  2010-03-18       Impact factor: 8.090

Review 2.  Biomimetic coatings for bone tissue engineering of critical-sized defects.

Authors:  Yuelian Liu; Gang Wu; Klaas de Groot
Journal:  J R Soc Interface       Date:  2010-05-19       Impact factor: 4.118

3.  Poly(lactide-co-glycolide)/hydroxyapatite nanofibrous scaffolds fabricated by electrospinning for bone tissue engineering.

Authors:  Lihong Lao; Yingjun Wang; Yang Zhu; Yuying Zhang; Changyou Gao
Journal:  J Mater Sci Mater Med       Date:  2011-06-18       Impact factor: 3.896

Review 4.  Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications.

Authors:  Wei Ji; Yan Sun; Fang Yang; Jeroen J J P van den Beucken; Mingwen Fan; Zhi Chen; John A Jansen
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

Review 5.  Drug delivery using composite scaffolds in the context of bone tissue engineering.

Authors:  Cecilia Romagnoli; Federica D'Asta; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

6.  Putting Electrospun Nanofibers to Work for Biomedical Research.

Authors:  Jingwei Xie; Xiaoran Li; Younan Xia
Journal:  Macromol Rapid Commun       Date:  2008-11-19       Impact factor: 5.734

7.  In vitro and in vivo studies of BMP-2-loaded PCL-gelatin-BCP electrospun scaffolds.

Authors:  Bo-Ram Kim; Thuy Ba Linh Nguyen; Young-Ki Min; Byong-Taek Lee
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

Review 8.  Regenerative endodontics: barriers and strategies for clinical translation.

Authors:  Jeremy J Mao; Sahng G Kim; Jian Zhou; Ling Ye; Shoko Cho; Takahiro Suzuki; Susan Y Fu; Rujing Yang; Xuedong Zhou
Journal:  Dent Clin North Am       Date:  2012-07

9.  Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres.

Authors:  Nathan H Dormer; Vineet Gupta; Aaron M Scurto; Cory J Berkland; Michael S Detamore
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-06-28       Impact factor: 7.328

10.  Synergistic and sequential effects of BMP-2, bFGF and VEGF on osteogenic differentiation of rat osteoblasts.

Authors:  Peipei Li; Yan Bai; Guangfu Yin; Ximing Pu; Zhongbing Huang; Xiaoming Liao; Xianchun Chen; Yadong Yao
Journal:  J Bone Miner Metab       Date:  2013-12-05       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.